Parkinson’s drug starves gut microbes of iron

Entacapone, a drug used in the treatment of Parkinson's disease, disrupts gut microbial communities by sequestering iron, creating a competitive advantage for iron-scavenging microbes that often carry antimicrobial resistance and virulence genes.